MOTION FOR A RESOLUTION
pursuant to Rule 143 of the Rules of Procedure
on creating a European compensation fund for victims of the ‘COVID-19 vaccines’
- Comirnaty (Pfizer, BioNTech)
- Janssen COVID-19 vaccine
- Spikevax (Moderna)
- Vaxzevria (AstraZeneca)
Virginie Joron
B9‑0475/2021
Motion for a European Parliament resolution on creating a European compensation fund for victims of the ‘COVID-19 vaccines’
The European Parliament,
– having regard to Rule 143 of its Rules of Procedure,
A. whereas the European Medicines Agency (EMA) has already recorded around a million cases of people experiencing adverse reactions from the COVID-19 vaccines:
- 435 779 due to the Pfizer BioNTech vaccine,
- 373 285 due to the AstraZeneca vaccine,
- 117 243 due to the Moderna vaccine,
- 27 694 due to the Janssen vaccine[1];
B. whereas these adverse reactions are sometimes severe; whereas around 75 000 people suffered from serious neurological effects as a result of taking the Pfizer vaccine;
C. whereas the EMA states that around 5 000 people have died in the EU as a result of taking the COVID-19 vaccines:
- 4 198 due to the Pfizer vaccine[2],
- 1 053 due to the AstraZeneca vaccine,
- 392 due to the Moderna vaccine,
- 138 due to the Janssen vaccine;
D. whereas the European Commission negotiated the purchase contracts and did not wish for the pharmaceutical companies to incur any liability; whereas MEPs were not granted access to the contracts during the negotiations;
1. Calls on the Commission to create a European compensation fund for victims of the COVID-19 vaccines;
2. Instructs its President to forward this resolution to the Commission and the Member States.
https://www.europarl.europa.eu/doceo/document/B-9-2021-0475_EN.html?fbclid=IwAR3r5jhvHEGf8nnG1coGUW2nWedsJoFAkseun1ec8KMoUzDKZcwu7-_OQe8
